Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Other 2Head & Neck 2CNS 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Weight Loss 1Muscular Atrophy 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Carcinoma, Bronchogenic 1

Interventions

Rituximab 689Cyclophosphamide 615Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 229Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 176Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106obinutuzumab 105Tacrolimus 105Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Acetylcysteine × Lymphoid × Clear all
NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

German Cancer Research Center

Phase 2 Completed
60 enrolled
GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡